Drug intelligence / Profile preview

low osmolar oral rehydration salts

Development stage
Phase 4
Lead developer
World Health Organization
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Oral
01

Overview

Low osmolar oral rehydration salts is a powdered formulation for oral rehydration therapy, containing a specific mixture of **glucose, sodium chloride, potassium chloride, and trisodium citrate dihydrate**. It is designed to be dissolved in one liter of water, creating a solution with a **total osmolarity of 245 mOsm/L**. The solution is used to treat and prevent dehydration caused by diarrheal diseases by leveraging the sodium-glucose cotransport mechanism in the intestines, which enhances water and electrolyte absorption. Compared to the older standard ORS, the low osmolar formulation contains **lower concentrations of sodium chloride and glucose but the same concentrations of potassium and citrate**. This modification reduces stool output, vomiting, and the need for intravenous fluids, especially in children, while maintaining clinical efficacy[1][3][7][10]. Citrate is included as a buffer to correct metabolic acidosis resulting from dehydration[1][5].

Brand names
OralytePedialyteReVitalMedi-Lyte
Other names
low-osmolarity oral rehydration saltslow-osmolar ORSreduced-osmolarity oral rehydration saltsWHO ORS (low-osmolar)LORS
02

Targets

SLC5A1 (Sodium Glucose Cotransporter 1)

Beyond the preview

Go deeper on low osmolar oral rehydration salts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on low osmolar oral rehydration salts.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call